Advertisement
Screener

AngioDynamics, Inc. (ANGO) Fair Value, Liability, Recurring Basis, Still Held, Unrealized Gain (Loss)

1.7 / 5 stars · 26/77 Roast Me

AngioDynamics, Inc. Fair Value, Liability, Recurring Basis, Still Held, Unrealized Gain (Loss)

AngioDynamics, Inc. (ANGO) reported Fair Value, Liability, Recurring Basis, Still Held, Unrealized Gain (Loss) of $8.40 million for the 3-month period ending 2019-05-31, per its 10-K filed 2019-07-25.

Discontinued › Income Statement › Other Income

us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss · last filed 2019-07-25

  • AngioDynamics, Inc. fair value, liability, recurring basis, still held, unrealized gain (loss) for the quarter ending 2019-05-31 was $8.40M.
Period endFair Value, Liability, Recurring Basis, Still Held, Unrealized Gain (Loss) 3 month
2019-05-31$8.40M
10-K · filed 2019-07-25

Similar stocks

Stock NameCountryMarket CapPE Ratio
ORTHOPEDIATRICS CORP (KIDS)United States$0.592B
SS Innovations International, Inc. (SSII)$0.589B-64.06
MIMEDX GROUP, INC. (MDXG)United States$0.687B89.92
DELCATH SYSTEMS, INC. (DCTH)United States$0.558B820.33
CERUS CORP (CERS)United States$0.525B-86.40
TACTILE SYSTEMS TECHNOLOGY INC (TCMD)United States$0.519B27.16
NeuroPace Inc (NPCE)United States$0.480B-28.52
Sight Sciences, Inc. (SGHT)United States$0.478B-9.95
ClearPoint Neuro, Inc. (CLPT)United States$0.446B-15.74
SI-BONE, Inc. (SIBN)United States$0.830B-49.82